EUDA: EUDA Health Holdings P/S Multiple

Symbol and logo of brand EUDA Health Holdings (EUDA)

The market capitalization-to-revenue ratio reflects market expectations, where 54.00 represents the current level of this metric. EUDA Health (EUDA) is developing an integrated digital healthcare environment in Southeast Asia, combining insurance and emergency care. Revenues are based on B2B telemedicine services and mobile ecosystems. In its active growth phase, the business aims to create a comprehensive health management platform by 2026.

EUDA: EUDA Health Holdings P/S Multiple 04/28/2023 - 11/13/2026

Analytical breakdowns for EUDA Health (EUDA)

Fundamental company analysis:EUDA Health Holdings EUDA
Mass-produced product of EUDA Health

For EUDA Health, which is developing a telemedicine platform in Southeast Asia, the revenue multiple serves as a tool for assessing market value relative to actual cash flows. This metric is calculated as the ratio of the business's market capitalization to its annual turnover, measuring the premium the market is willing to pay per unit of sales. By analyzing the price-to-sales ratio, an investor determines the degree of the asset's overvaluation. Amidst fierce competition among IT startups, this indicator reveals the effectiveness of the company's monetization of its network effect.

Who EUDA Health competes with

hcahealthcare.com - Market Cap to Revenue Ratio|P/S Multiple THC (Tenet Healthcare Corporation)|P/S Multiple Fresenius Medical Care AG FMS|SOLV: Market Cap to Revenue|Market Capitalization-to-Revenue Ratio EHC (Encompass)|UHS: P/S Multiple|davita.com - Market Capitalization-to-Revenue Ratio|RDNT (RadNet) - P/S Multiple|Price to Sales Option Care OPCH|P/S Multiple SGRY|P/S Multiple Premier Health (PINC)|Price-to-Revenue Ratio National Vision Holdings EYE|progyny.com - Price-to-Revenue Ratio|ARDT: Market Cap to Revenue|Select Medical Corporation - Market Cap to Sales Volume|ASTH: P/S Multiple|MEDNAX - Market Capitalization-to-Revenue Ratio|USPH (US Physical Therapy) - P/S Multiple|Price to Sales pennantgroup.com PNTG|Market Cap to Revenue ORGO (Organogenesis)|P/S Multiple Nutex Health Inc (NUTX)|P/S Multiple AUNA (Auna Health)|SBC: Market Cap to Revenue Ratio|Evolus, Inc. - P/S Multiple|CYH - P/S Multiple|SKIN (beautyhealth.com) - Market Cap to Revenue|MDWD: Market Cap to Sales Volume|Price-to-Revenue Ratio Biote Corp|JYNT: Market Capitalization-to-Revenue Ratio|P/S Multiple DCGO|PIII - Price to Sales|P/S Multiple GANX (Gain Therapeutics)|P/S Multiple Basel Medical BMGL|CLGN: Market Cap to Revenue|Cuprina Holdings Limited - Market Cap to Sales Volume|Concord Medical Services (CCM) - Price-to-Revenue Ratio|Market Cap to Revenue ashs.com|MRM (MEDIROM Healthcare Group) - P/S Multiple|Price to Sales Avalon GloboCare Corporation ALBT|Price-to-Revenue Ratio DIH Holding US Inc. (DHAI)|Carmell Corp - Market Cap to Revenue Ratio|NewGenIvf Group Limited - Market Cap to Revenue|Market Cap to Sales Volume ATIP (ATI Physical Therapy Inc.)|CareMax - P/S Multiple|Price to Sales Kindly MD Inc|MODV (LogistiCare) - Market Cap to Revenue|Novo Integrated Sciences Corp (NVOS) - P/S Multiple|SSY (SunLink Health Systems Inc.) - P/S Multiple|Market Cap to Revenue Ratio BACK (imacholdings.comm)